Solid Biosciences Inc. - SLDB
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 17, 2026 | SCHEDULE 13D/A | — | 9.9% | — | View |
| Mar 11, 2026 | SCHEDULE 13D/A | — | 9.99% | — | View |
| Mar 10, 2026 | SCHEDULE 13D/A | — | 9.99% | — | View |
| Mar 10, 2026 | SCHEDULE 13D/A | — | 9.9% | — | View |
| Feb 17, 2026 | SCHEDULE 13G | Vestal Point Capital, LP | 7.5% | 5,815,000 | View |
| Feb 17, 2026 | SCHEDULE 13G | Ryan Wilder | 7.5% | 5,815,000 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Adage Capital Management, L.P. | 1.8% | 1,400,000 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Robert Atchinson | 1.8% | 1,400,000 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Phillip Gross | 1.8% | 1,400,000 | View |
| Nov 13, 2025 | SCHEDULE 13G/A | Adage Capital Management, L.P. | 5.14% | 4,000,000 | View |
| Nov 13, 2025 | SCHEDULE 13G/A | Robert Atchinson | 5.14% | 4,000,000 | View |
| Nov 13, 2025 | SCHEDULE 13G/A | Phillip Gross | 5.14% | 4,000,000 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.